According to Actinium Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -S$60.85 M. In 2023 the company made an earning of -S$67.63 M a decrease over its 2022 earnings that were of -S$44.43 M.The earnings displayed on this page is the company's Pretax Income.